Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 852 of 1,261

  1. US 8536132

    Lymphatic zip codes in tumors and pre-malignant lesions

    The Regents of the University of California · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  2. US 8535639

    Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  3. US 8535260

    Devices, systems, and methods for localized drug delivery

    Compass Therapeutics LLC · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  4. US 8536335

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  5. US 8536147

    Antibacterial antisense oligonucleotide and method

    Sarepta Therapeutics, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  6. US 8536136

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  7. US 8536148

    Disabling autophagy as a treatment for lysosomal storage diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  8. US 8536133

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  9. US 8535712

    Radiation sensitive liposomes

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  10. US 8535687

    Smallpox DNA vaccine and the antigens therein that elicit an immune response

    Inovio Pharmaceuticals, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  11. US 8535667

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  12. US 8535890

    Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies

    The United of America as represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  13. US 8535689

    Identification of bacterial autoinducer and use in treating bacterial pathogenicity

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  14. US 8535656

    Amphiphilic polymer-protein conjugates and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  15. US 8536149

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  16. US 8536363

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  17. US 8536206

    Process for the preparation of roflumilast

    TAKEDA GMBH · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  18. US 8536195

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  19. WO 2013133980

    DÉRIVÉS NITROXY DE STÉROÏDES DOUX

    BAUSCH & LOMB [US] · Granted Sep 12, 2013 · Expires Sep 7, 2033

    granted

  20. US 8530405

    Method of preparing water-soluble and biodegradable antimicrobial agent

    FAR EASTERN NEW CENTURY CORPORATION · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  21. US 8530516

    Promoting cycling of ApoE4 isoform

    The Board of Regents of the University of Texas System · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  22. US 8530656

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  23. US 8530489

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  24. US 8529885

    AAV vectors for in vivo gene therapy of rheumatoid arthritis

    ACADEMISCH MEDISCH CENTRUM · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.